09/10/2026
🔬 PDT Across Ophthalmology | Meet Modulight at AAO 2026
Photodynamic therapy (PDT) continues to play an important role in retinal care, while research explores new possibilities in ocular oncology.
👁️ One laser platform. Multiple ophthalmic applications.
The ML6710i supports PDT across established retinal indications, including exudative AMD, PCV and CSR, while also supporting investigational applications in ocular oncology.
⚙️ Designed for flexibility
FDA-approved for PDT treatment of exudative AMD
Configurable for investigational ocular oncology applications
Intuitive iOS-based control and cloud connectivity
Pay-Per-Treatment model to support access to the technology
📍 Meet Modulight at AAO 2026 in New Orleans — Booth #854 — and discover how the ML6710i platform can support your ophthalmic PDT needs, from established treatments to emerging research.
🔗 Explore the ML6710i: https://modulight.com/ml6710i/